Meghmani Organi. Q1 FY27 Share Price & Earnings Call Analysis

Financials of Meghmani Organi.

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Meghmani Organi.

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +574.08425.78378.72351.75410.03413.88543.89568.51553.46613.62577.26508.74474.34
Expenses +496.18447.87371.13359.55408.01408.01513.32527.69487.98546.73525.17471.01454.62
Operating Profit77.90-22.097.59-7.802.025.8730.5740.8265.4866.8952.0937.7319.72
OPM %13.57%-5.19%2.00%-2.22%0.49%1.42%5.62%7.18%11.83%10.90%9.02%7.42%4.16%
Other Income +27.417.0112.109.638.958.8811.979.1413.8816.5827.7614.8437.24
Interest15.754.4712.7726.632.4910.5826.2212.8819.3229.4723.7818.1320.48
Depreciation22.5823.5922.7123.1322.8023.4825.4929.6729.4929.7029.9829.9429.33
Profit before tax66.98-43.14-15.79-47.93-14.32-19.31-9.177.4130.5524.3026.094.507.15
Tax %19.15%-20.03%-2.85%-20.26%25.42%-13.26%1.09%159.24%35.12%47.78%55.73%178.67%-12.45%
Net Profit +54.15-34.50-15.34-38.23-17.96-16.76-9.27-4.3919.8212.6811.55-3.538.03
EPS in Rs2.13-1.36-0.60-1.50-0.71-0.66-0.36-0.170.780.500.45-0.140.32

Financials of Meghmani Organi.

Profit & Loss

Annual income statement trend

Mar 2020 6mMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +7001,6372,4982,5531,5662,0802,174
Expenses +5951,3532,1192,2111,5861,9361,998
Operating Profit105283379342-19144176
OPM %15%17%15%13%-1%7%8%
Other Income +13030102114374296
Interest1811966466992
Depreciation2251637792108119
Profit before tax194252409313-121962
Tax %23%26%26%24%-12%212%54%
Net Profit +150186304238-106-1129
EPS in Rs29,914.0037,296.0011.979.35-4.17-0.421.13
Dividend Payout %17%19%12%15%0%0%0%

Financials of Meghmani Organi.

Balance Sheet

Capital structure and asset base

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital25252525252525
Reserves9611,1481,4411,6441,5021,4901,519
Borrowings +264268499824837829726
Other Liabilities +407533832705674741750
Total Liabilities1,6571,9742,7983,1983,0393,0853,021
Fixed Assets +4816349111,1661,1521,5751,503
CWIP1011121883565218379
Investments19130421118311435
Other Assets +8859241,4871,4941,2511,4251,435
Total Assets1,6571,9742,7983,1983,0393,0853,021

Financials of Meghmani Organi.

Cash Flows

Operating, investing and financing cash movement

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +223336520425066222
Cash from Investing Activity +13-307-133-418-17831-38
Cash from Financing Activity +-26-1458234-85-91-190
Net Cash Flow812-1021-146-7
Free Cash Flow-49124-177-259-14-20178
CFO/OP48%143%42%84%-1,328%49%142%

Financials of Meghmani Organi.

Ratios

Working capital efficiency and return ratios

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days24192797510199113
Inventory Days271152161158185173145
Days Payable209137144108176159149
Cash Conversion Cycle30210696124110113110
Working Capital Days152895753262011
ROCE %19%24%16%-3%3%7%

Continue your research

What Meghmani Organi.'s management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • GSP Crop Science (Q1 FY27)

    Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…

  • Sharda Cropchem (Q4 FY25)

    Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them…

  • Sumitomo Chemi. (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

  • Indogulf Cropsci (Q3 FY26)

    The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…

Compare:vs Coromandel Intervs F A C Tvs UPL